International Patent: THERAPEUTIC AGENTS CONJUGATED TO A LINKER-DRUG TO MITIGATE ANTI-DRUG ANTIBODY FORMATION

GENEVA, Oct. 1 -- ONCOC4, INC. filed a patent application (US2026/018997) for “THERAPEUTIC AGENTS CONJUGATED TO A LINKER-DRUG TO MITIGATE ANTI-DRUG ANTIBODY FORMATION”. With publication no. WO/2026/193333, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: A61K 47/60

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....